# FDA recall D-422-2013

> **King Legacy, a wholly owned subsidiary of Pfizer** · Class II · drug recall initiated 2013-04-30.

## Product

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620

## Reason for recall

Subpotent Drug: The products were below specification for potency at the expiry stability point.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-422-2013
- **Recalling firm:** King Legacy, a wholly owned subsidiary of Pfizer
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-30
- **Report date:** 2013-05-29
- **Termination date:** 2016-06-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bristol, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-422-2013

## Citation

> AI Analytics. FDA recall D-422-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-422-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*